Director, Stakeholder Engagement Strategy & Operations, Ad Boards
About the role
Revolution Medicines is a global, commercial-state oncology company dedicated to discovering, developing and delivering innovative medicines for patients with RAS-addicted cancers. Leveraging its differentiated RAS(ON) tri-complex inhibitor platform, the company is advancing a broad, integrated portfolio of oral RAS(ON) inhibitors designed to directly target the active, cancer-driving state of RAS. Founded on rigorous scientific inquiry and a willingness to challenge long-held assumptions, Revolution Medicines is committed to changing the trajectory of disease for patients with RAS-addicted cancers worldwide. Our people are united by a shared way of working: follow the science, challenge assumptions, act with urgency and hold ourselves to a high standard of rigor—all in service of patients.
As part of our expanding Medical Affairs organization, we seek a dynamic and experienced Director, Stakeholder Engagement Strategy & Operations to lead the strategy, planning, and execution of Global Medical Advisory Boards. This role may also have a more limited contribution to global congress planning, ensuring seamless integration of advisory boards with congress objectives and broader Medical Affairs priorities. This individual will report to the Head of Scientific Stakeholder Engagement within Global Medical Excellence and will partner cross-functionally with Commercial, Clinical Development, and Research, maintaining leadership for global advisory boards and ensuring seamless integration with broader Medical Affairs priorities.
Responsibilities
- Lead Medical Affairs advisory board strategy, planning, and execution for specific global and U.S. regional advisory boards, ensuring alignment with medical strategy, stakeholder engagement priorities, and key congress activities.
- Collaborate across Medical Affairs to develop and align global and regional advisory board tactical plans with broader Medical Affairs priorities.
- Ensure compliant planning,